Evaluation of Anticancer
Activity of Ethanolic and Ethylacetoacetate Extracts of Sweet Cherry Against
Human Breast Cancer Cell Line MCF-7
M. Lavanya1, Asish
Bhaumik2*, A. Gopi Reddy3, Ch. Manasa1, B.
Kalyani1, S. Sushmitha1
1,2Department of Pharmaceutical Chemistry, Teja College
of Pharmacy, Kodad, Nalgonda-508206, Telangana State, India.
3Department of Pharmaceutical Chemistry, SANA College
of Pharmacy, Kodad, Nalgonda-508206, Telangana State, India.
*Corresponding Author E-mail: bhaumik.asish@gmail.com
ABSTRACT:
MCF-7 is a breast cancer cell line isolated in 1970
from a 69-year-old Caucasian woman. MCF-7 is the acronym of Michigan Cancer
Foundation-7, referring to the institute in Detroit where the cell line was
established in 1973 by Herbert Soule and co-workers. The MCF7 line retains
several characteristics of differentiated mammary epithelium including ability
to process estradiol via cytoplasmic estrogen receptors and the capability of
forming domes. The cells express the WNT7B oncogene. Growth of MCF7 cells is
inhibited by tumor necrosis factor alpha (TNF alpha). Secretion of IGFBP's can
be modulated by treatment with anti-estrogens. PIK3CA helical mutations were
identified in MCF-7, but with low AKT activation. The main objective of the
present research work is to isolate the bioactive molecules and evaluate the in
vitro anticancer activity of ethanolic and ethyl acetoacetate extracts of sweet cherry
(EEC and EAAEC) of Prunus avium. The in vitro anticancer activity was carried
out against human breast cancer cell line MCF-7 by MTT assay. The results
obtained from the in-vitro studies performed by MTT assay by using human breast
cancer cell line MCF-7 displayed that the various extracts of sweet cherry (EEC
and EAAEC) possessed a very good anticancer activity. From the present studied
it had been concluded that EEC and EAAEC, all were exhibiting the potential
capability to inhibit the cancer cell when compared with standard drug
doxorubicin and the cell growth inhibition of EEC and EAAEC was found to be the
highest 92.90% growth inhibition at
10 µg (IC50 = 2.4 µg/ml)
and EAAEC with the 92.49% growth
inhibition at 10 µg (IC50 = 2.9
µg/ml).
KEYWORDS: MCF-7,
WNT7B oncogene, TNF alpha, anticancer,
MTT assay, IC50 etc.
INTRODUCTION:
Wonderfully delicious, cherry fruit is packed with
full of health-benefiting nutrients and unique antioxidants. Cherries are
native to Eastern Europe and Asia Minor regions. Botanically, the fruit is a
“drupe” (stone fruit), belonging to the broad Rosaceae family of small tree
fruits in the genus, Prunus. Some of the common “drupe” family fruits are
plums, peaches, apricots etc.
Although several species of cherries exist, two
popular cultivars are wild or sweet-cherry, and sour or tart-cherry. While
sweet cherries belong to the species of Prunus avium, tart variety belongs to
that of Prunus cerasus. Cherries are drupe fruits with a central “stony-hard”
seed surrounded by fleshy edible pulp measuring about 2 cm in diameter.
Externally they covered by bright "shiny" red or purple, thin peel.
The West Indian cherry, known as acerola (Malpighia
emarginata) is native to West Indian islands and grown in Mexico, Texas
regions in North America. Acerola belongs to tropical fruit-bearing shrub or
small tree in the family Malpighiaceae and contains 2-3 tiny seeds. Acerola
contains exceptionally high levels of vitamin-C and vitamin-A than North
American and European cherries. Cherries are one of the very low calorie
fruits. Nonetheless, they are rich source of phytonutrients, vitamins, and
minerals. Both sweet as well as tart cherries are packed with numerous health
benefiting compounds that are essential for wellness. Cherries are pigment rich
fruits. These pigments, in fact, are polyphenolic flavonoid compounds known as
anthocyanin glycosides. Anthocyanins are red, purple or blue pigments found in
many fruits and vegetables, especially concentrated in their skin, known to
have powerful anti-oxidant properties.
Fig: Cherry fruits
Scientific studies have shown that anthocyanins in the
cherries are found to act like anti-inflammatory drugs by blocking the actions
of enzymes cyclooxygenase-1 and 2. Thus, consumption of cherries may offer
potential health effects against chronic painful episodes such as gout
arthritis, fibromyalgia (painful muscle condition) and sports injuries.
Research studies also suggest that anti-oxidant compounds in tart cherries can
help the human body to fight against cancers, aging and neurological diseases,
and pre-diabetes condition. Cherries compose of melatonin anti-oxidant.
Melatonin can cross the blood-brain barrier easily and has soothing effects on
the brain neurons, calming down nervous system irritability. It, thus, can help
relieve neurosis, insomnia and headache problems [1-2].
Cherry texonomy[3]:
Cherries are
members of the Rosaceae family, subfamily Prunoideae. They occupy the Cerasus
subgenus within Prunus, being fairly distinct from their stone fruit relatives
plums, apricots, peaches, and almonds. Prunus avium L. is the Sweet Cherry, and
Prunus cerasus L. the Sour, Pie, or Tart Cherry.
Botanical description:
Plant: Sweet
Cherry. Vigorous tree with strong apical control with an erect-pyramidal canopy
shape, capable of reaching 50 ft. In cultivation, sweet cherries are maintained
12-15 ft in height. Leaves are relatively large (largest of cultivated Prunus),
elliptic with mildly serrate margins, acute tips, petioled, and strongly
veined.
Sour Cherry.
Medium sized tree with a rounder, more spreading habit than the erect sweet
cherry. Kept <15 ft in cultivation. Leaves elliptic with acute tips, mildly
serrate margins, smaller than sweet cherry, with long petioles.
Flowers:
Sweet Cherry. White, with long pedicels, borne in
racemose clusters of 2-5 flowers on short spurs with multiple buds at tips; the
distal bud is vegetative and continues spur growth. Spurs are long-lived,
producing for 10-12 years. Ovary position. is perigynous with a distinct
hypanthium, characteristic of stone fruits. Sour Cherry. Individual flowers are
the same as for sweet cherry. Sour cherry inflorescence buds usually produce
2-4 flowers, with long pedicels, as in sweet cherry. However, many are borne
laterally on 1-yr wood, not exclusively on spurs as in sweets. Spurs are
shorter-lived on sour than sweet, gradually declining in productivity over 3-5
years. Sour cherries are the latest blooming of the stone fruits.
Pollination:
Sweet Cherry. Pollination is absolutely essential for
production, since sweet cherries are self-incompatible and need a high degree
of fruit set (25-50%) for a commercial crop. In addition to
self-incompatibility, there is a high degree of cross-incompatibility.
Pollinizers are set every third tree in every third row, or a ratio of 8-9:1.
Honey bees are the main pollinator.
Sour Cherry:
Sour cherries are self-fertile, and require no
pollinizers.
Sweet Cherry:
A drupe; ½” to 1 1/4″, round or heart-shaped,
glabrous, with long pedicel attached. The pit is generally smooth, and encloses
a single seed. The skin color is generally deep red or purple (often referred
to as “black”), yellow, or rarely white. Yellow fruit often have a red cheek.
The flesh color varies from white to dark red. Fruit is borne on short spurs
that arise from older wood. Sweet cherries require only about 2-3 months for
fruit development. Thinning is unnecessary.
Pharmacological actions [4]:
Cherries are a
nutritional powerhouse fruit with so many incredible health benefits. One cup
of raw cherries has 87 calories, 22 grams of carbohydrates, 1 gram of protein
and 3 grams of fiber. Enjoy them now while they are at their peak because their
season is way too short. Read on for some of the great health benefits of
eating cherries.
Ten Great Health Benefits of Eating
Cherries:
1. Cherries,
known as a “super-fruit”, are packed with antioxidants called anthocyanins
which aid in the reduction of heart disease and cancer.
2. Cherries are
one of the few food sources that contain melatonin, an antioxidant that helps
regulate heart rhythms and the body’s sleep cycles.
3. Cherries are
an excellent source of beta carotene (vitamin A). In fact they contain 19 times
more beta carotene than blueberries and strawberries.
4. Cherries are
rich in vitamins C, E, potassium, magnesium, iron, folate and fiber.
5. Cherries are
referred to as “brain food”, aiding in brain health and in the prevention of
memory loss.
6. Because
cherries contain anthocyanins, they can reduce inflammation and symptoms of
arthritis and gout.
7. Eating cherries
reduces the risk of diabetes.
8. Cherries are a
good source of fiber which is important for digestive health.
9. Cherries are a
great snack or dessert choice important for weight-maintenance.
10. Because of
their powerful anti-inflammatory benefits, cherries are said to reduce pain and
joint soreness for runners and athletes after workouts.
MATERIALS AND METHOD:
Drugs and chemicals:
The standard drug
doxorubicin purchased from Local Retail Pharmacy Shop and solvents and other
chemicals used for the extraction and phytochemical screening were provided by
Institutional Store and were of LR and AR grade.
Cell culture:
The human breast
cancer cell line MCF-7 cell line was provided by National Centre for Cell
Science (NCCS), Pune and was grown in Eagles Minimum Essential Medium (EMEM)
which contained 10% fetal bovine serum (FBS). All cells were maintained at
37°C, 100% relative humidity, 5% CO2, 95% air and the culture medium was
changed twice a week.
Apparatus:
Round bottom
flask, water condenser, heating mantle, motor and pestle.
Methodology [5]:
Weigh 20 g of sweet cherry fruits paste (ripen can be
mashed to prepare a paste) into a 250 ml round-bottomed flask. Add 50 ml of
ethanol and 60 ml of dichloromethane. Heat the mixture under reflux for 5 min
on stem-bath with frequent shaking. Filter the mixture under suction and
transfer the filtrate to a separating funnel. Wash this mixture containing
bioactive compounds with three portions of 150 ml each with sodium chloride
solution. Dry the organic layer over anhydrous magnesium sulfate. Filter and
evaporate most of the solvent in vacuum without heating and obtained ethanolic
extract of sweet cherry (EEC) of Prunus avium. Same procedure was followed for
the preparation of ethylacetoacetate extract of sweet cherry (EAAEC) of Prunus
avium.
Phytochemical screening [6-8]:
Preliminary
Phytochemical screening of ethanolic and ethyl acetoacetate extracts of sweet
cherry of Prunus avium had shown the presence of various bioactive compounds
such as carbohydrates, amino acids and peptides, phytosterols, carotenoids,
and polyphenols etc.
Evaluation of anticancer activity of EEC
and EAAEC of sweet cherry (Prunus avium)
by MTT assay:
Principle
[9]: The MTT assay is a colorimetric assay for assessing cell viability.
NAD(P) H-dependent cellular oxidoreductase enzymes may, under defined
conditions, reflect the number of viable cells present. These enzymes are
capable of reducing the tetrazolium dye MTT
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide to its insoluble
formazan, which has a purple color. Other closely related tetrazolium dyes
including XTT, MTS and the WSTs, are used in conjunction with the intermediate
electron acceptor, 1-methoxy phenazine methosulfate (PMS).With WST-1, which is
cell-impermeable, reduction occurs outside the cell via plasma membrane
electron transport[36]. Tetrazolium dye assays can also be used to measure
cytotoxicity (loss of viable cells) or cytostatic activity (shift from
proliferation to quiescence) of potential medicinal agents and toxic materials.
MTT assays are usually done in the dark since the MTT reagent is sensitive to
light.
Screening of in vitro
anticancer activity by MTT assay [10-12]
Cell culture:
The human breast cancer cell line MCF-7 was provided
by National Centre for Cell Sciences, Pune, India and was grown in Eagles
Minimum Essential Medium (EMEM) which contained 10% fetal bovine serum (FBS).
All cells were maintained at 37°C, 100% relative humidity, 5% CO2, 95% air and
the culture medium was changed twice a week.
Cell treatment:
The monolayer cells were detached and single cell
suspensions were made using trypsin-ethylene diaminetetraacetic acid (EDTA). A
hemocytometer was used to count the viable cells and the cell suspension was
diluted with a medium containing 5% FBS in order to obtain final density of
1x105 cells/ml. 96-well plates at plating density of 10,000
cells/well were seeded with one hundred microlitres per well of cell suspension
and incubated for cell attachment at 37° C, 5% CO2, 95% air and 100% relative
humidity. The cells were treated with serial concentrations of the test samples
after 24 hr. Serial dilution method was used for preparing test extracts (EEC
and EAAEC) of different concentrations. Cells were initially dissolved in dimethylsulfoxide
(DMSO) and further diluted with serum free medium to obtain twice the desired
final maximum test concentration. The required final extract concentrations of
10, 20, 30, 40 and 50 µg/ml were obtained by adding aliquots of 100 µl of the
different extract dilutions to the appropriate wells already containing 100 µl
of medium. After addition of the test extract the plates were incubated for an
additional 48 hr at 37° C, 5% CO2, 95% air and 100% relative humidity. The
medium without samples served as control and triplicate was maintained for all
concentrations.
MTT assay:
After 48h of incubation, to each well 15µl of MTT (5
mg/ml) in phosphate buffered saline (PBS) was added and incubated at 37° C for
4h. The medium with MTT was flicked off and the formed formazan crystals were
solubilized in 100 µl of DMSO. Using micro plate reader the absorbance was
measured at 570 nm. The % cell inhibition was determined using the following
formula:
% Cell Inhibition =
[100 - Abs (sample)/Abs (control)] x100.
RESULTS AND DISCUSSION:
The results
for cell growth inhibition by the extracts such as EEC and EAAEC against MCF-7
cell lines for various concentrations is shown in table 1 and 2. As the
concentration increases there is an increase in the cell growth inhibition and
it was found that EEC with the highest 92.90% growth inhibition at 10 µg (IC50
= 2.4 µg/ml) and EAAEC with the 92.49% growth inhibition at 10 µg (IC50 =
2.9 µg/ml). In the USNCI screening program a compound is generally considered
to have in vitro anticancer activity, if the IC50 value following
incubation between 48 hrs and 72 hrs is less than 4 µg/ml or 10 µM. In the
present study IC50 values
below 4 µg/ml were displayed by the various extracts of sweet cherry of Prunus avium. The IC50 value
of standard drug doxorubicin was found to be 1.3 µg/ml with 96.62 % growth inhibition at concentration 75 µg/ml.
Table 1: For percentage (%) of cell growth inhibition of ethanolic
extract of cherry fruits (EEC) on MCF-7 Cell lines by MTT Assay
|
S. no. |
Concentration of the Extracts |
Absorbance of extracts |
Inhibition of cell growth (%) |
|
1 |
10 µg/ml |
0.021 |
92.90 |
|
2 |
20 µg/ml |
0.036 |
87.83 |
|
3 |
30 µg/ml |
0.049 |
83.44 |
|
4 |
40 µg/ml |
0.060 |
79.72 |
|
5 |
50 µg/ml |
0.079 |
73.31 |
|
6 |
75 µg/ml of
Dox. (Doxorubicin) |
0.010 |
96.62 |
|
7 |
Control |
0.296 |
0 |
Fig1:
Percentage (%) of cell
growth inhibition by EEC on human
breast cancer MCF-7 cell line.
Table 2: For percentage (%) of cell growth inhibition of ethyl
acetoacetate extract of cherry fruits (EAAEC) on MCF-7 Cell lines by MTT Assay:
|
S. no. |
Concentration of
the Extracts |
Absorbance of
extracts |
Inhibition of
cell growth (%) |
|
1 |
10 µg/ml |
0.022 |
92.49 |
|
2 |
20 µg/ml |
0.038 |
87.16 |
|
3 |
30 µg/ml |
0.052 |
82.43 |
|
4 |
40 µg/ml |
0.066 |
77.70 |
|
5 |
50 µg/ml |
0.081 |
72.63 |
|
6 |
75
µg/ml (Doxorubicin) |
0.010 |
96.62 |
|
7 |
Control |
0.296 |
0 |
Fig2: Percentage
(%) of cell growth inhibition by EAAEC on human breast cancer MCF-7 Cell line.
Fig3: Percentage (%) of cell growth inhibition by EEC and EAAEC
on human breast cancer MCF-7 cell line.
CONCLUSION:
The results obtained from the present studies displayed that the Preliminary Phytochemical screening of ethanolic and ethyl acetoacetate
extracts of sweet cherry of Prunus. avium had shown the presence of
various bioactive compounds such as carbohydrates, amino acids and peptides,
phytosterols, carotenoids, and
polyphenols etc and results obtained from the in-vitro
studies performed by MTT assay by using the human breast cancer MCF-7 cell
line. MCF-7 cell lines displayed that the various extracts of sweet cherry (EEC
and EAAEC) possessed a very good anticancer activity. From the present studied
it had been concluded that EEC and EAAEC, all were exhibiting the potential
capability to inhibit the cancer cell when compared with standard drug
doxorubicin and the cell growth inhibition of EEC and EAAEC was found to be the highest 92.90% at 10 µg
(IC50 = 2.4 µg/ml) and 92.49% at 10 µg (IC50 = 2.9
µg/ml).
REFERENCES:
1.
USDA
National Nutrient Database.
2.
Stanford
School of Medicine Cancer information Page- Nutrition to Reduce Cancer Risk.
3.
http://www.fruit-crops.com/cherry-prunus-avium-cerasus.
4.
http://www.ingredientsinc.net/2011/08/top-10-health-benefits-of-cherries-a-true-superfruit.
5.
Raj. K.
Bansal ,Laboratory manual of organic chemistry , 5th revised edition , PP-
238-239.
6.
P.C
Dandiya, P.K. Sharma , Bio-chemistry and clinical pathology, second edition,
PP- 17-18, 24, 47-48.
7.
Dr. G.
Devala Rao, A Manual of Practical Biochemistry, pp 17.
8.
Jaswant
Kaur, PV Chemistry of Natural Products,
2010 edition, PP-113-114, 116, 344-346, 381.
9.
Berridge
MV, Herst PM , and Tan AS. Tetrazolium dyes as tools in cell biology: new
insights into their cellular reduction. Biotechnology Annual Review, 11:
127-152 (2005).
10. Sathish M, Tharani CB, Niraimathi V,
Satheesh Kumar D, In-vitro cytotoxic activity on roots of Clerodendrum
phlomidis against NIH 3T3 cell line and Hela cell line. Pharmacologyonline
2011; 3: 1112-1118.
11. Pranay Dogra, Study of Antibacterial and
Anticancer Activity of Selected Trifoliate Plants. Biofrontiers 2009; 1(2): 48.
12. Rajesh M Patel, Sahil K Patel, Cytotoxic
activity of methanolic extract of Artocarpus heterophyllus against A549, Hela
and MCF-7 cell lines. Journal of Applied Pharmaceutical Science 2011; 01(07):
167-171.
Received
on 29.04.2016 Modified on 28.05.2016
Accepted
on 10.06.2016 ©A&V Publications All right reserved
Research J. Pharmacology & Pharmacodynamics.2016;
8(2): 65-70
DOI: 10.5958/2321-5836.2016.00012.4: